Congenital Long-QT Syndromes: a Clinical and Genetic Update from Infancy Through Adulthood
Overview
Authors
Affiliations
Long-QT syndromes (LQTSs) have been described in all ages and are a significant cause of cardiovascular mortality, especially in structurally normal hearts. Abnormalities in transmembrane ion conduction channels and structural proteins produce these clinical syndromes, labeled LQT1-LQT12; however, genotype-positive patients still represent only about 70% of LQTSs. Future research will determine the etiology of the remaining cases, further risk-stratify the known genetic defects, improve current treatment options for these syndromes, and uncover novel therapies.
Azithromycin Causes a Novel Proarrhythmic Syndrome.
Yang Z, Prinsen J, Bersell K, Shen W, Yermalitskaya L, Sidorova T Circ Arrhythm Electrophysiol. 2017; 10(4).
PMID: 28408648 PMC: 5396181. DOI: 10.1161/CIRCEP.115.003560.
Pathogenesis and management of Brugada syndrome.
Sieira J, Dendramis G, Brugada P Nat Rev Cardiol. 2016; 13(12):744-756.
PMID: 27629507 DOI: 10.1038/nrcardio.2016.143.
Jesty S, Jung S, Cordeiro J, Gunn T, Di Diego J, Hemsley S J Vet Cardiol. 2013; 15(1):5-14.
PMID: 23434243 PMC: 9124137. DOI: 10.1016/j.jvc.2012.07.005.
Atrial Fibrillation and Long QT Syndrome Presenting in a 12-Year-Old Girl.
Knoche J, Orland K, January C, Maginot K Case Rep Pediatr. 2012; 2012:124838.
PMID: 23193492 PMC: 3501806. DOI: 10.1155/2012/124838.
Van der Bijl P, Heradien M, Doubell A, Brink P Cardiovasc J Afr. 2012; 23(10):541-5.
PMID: 23192258 PMC: 3721884. DOI: 10.5830/CVJA-2012-060.